Contact
Please use this form to send email to PR contact of this press release:
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
TO:
Please use this form to send email to PR contact of this press release:
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
TO: